The procedure is not recommended during pregnancy and breastfeeding, or in people allergic to the ingredients of the infusion
Postmenopausal osteoporosis (type I): After menopause, women experience a sudden drop in estrogen levels, a significant increase in osteoclast activity, accelerated bone resorption, insufficient osteoblast activity, and rapid loss of bone mass (30% -50% loss after 5-10 years of menopause), mainly in the lumbar spine and hip
Upregulates growth factors such as VEGF (vascular endothelial growth factor) and FGF (fibroblast growth factor), accelerating wound repair
Because your body is constantly dealing with oxidative stress from the environment, diet, and exercise, providing regular antioxidant support can help maintain balance
Unlike natural IGF-1, which has a short lifespan, this version remains active for up to 20 to 30 hours